- Previous Close
4,505.00 - Open
4,360.00 - Bid 4,550.00 x --
- Ask 4,565.00 x --
- Day's Range
4,360.00 - 4,565.00 - 52 Week Range
4,095.00 - 6,840.00 - Volume
10,418 - Avg. Volume
64,359 - Market Cap (intraday)
49.379B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield 160.00 (3.50%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
--
Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.
www.nicepharma.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 014570.KQ
View MorePerformance Overview: 014570.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 014570.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 014570.KQ
View MoreValuation Measures
Market Cap
49.38B
Enterprise Value
30.46B
Trailing P/E
16.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
0.63
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
4.31
Financial Highlights
Profitability and Income Statement
Profit Margin
4.10%
Return on Assets (ttm)
2.87%
Return on Equity (ttm)
3.86%
Revenue (ttm)
73B
Net Income Avi to Common (ttm)
3B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
19B
Total Debt/Equity (mrq)
0.10%
Levered Free Cash Flow (ttm)
3.63B